The FDA announced a nationwide recall of Silintan joint pain supplements after testing found undeclared meloxicam, a ...

Three dietary supplements were recalled across the United States last week due to undeclared ingredients that could raise ...

The Global Meloxicam Market is estimated to be valued at USD 8.15 Bn in 2025 and is expected to reach USD 12.34 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.

A dietary supplement marketed for joint and body aches has been pulled from shelves nationwide after federal regulators ...

Silintan capsules are recalled after the Food and Drug Administration found they were tainted with another drug.

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

Aaron Navarro is a CBS News digital reporter. He covered the 2024 elections and was previously an associate producer for the CBS News political unit in the 2021 and 2022 election cycles. Washington — ...

More than 11,000 bottles of a common blood pressure medication have been recalled nationwide. Bisoprolol fumarate and hydrochlorothiazide tablets made by Glenmark Pharmaceuticals may contain trace ...

The federal government has announced the results of the latest round of Medicare drug price negotiations: 15 lower drug prices for Medicare to go into effect in 2027. Medicare will get a 71% discount ...

Popular weight loss drugs like Wegovy and Zepbound will soon cost Americans less under a new deal announced by President Donald Trump on Thursday. Agreements with drugmakers Novo Nordisk and Eli Lilly ...

President Donald Trump announced a deal Thursday, Nov. 6 with drugmakers Eli Lilly and Novo Nordisk to cut prices of their popular weight-loss drugs and expand Medicare coverage of these medications ...